Sign inJoin waitlistJoin the waitlist

Nicole Lamanna

Chief of Leukemia Service, Hematologic Malignancies · Vagelos College of Physicians and Surgeons

Credentials: · · ·

History

Hematologic Malignancies Division · Vagelos College of Physicians and Surgeons
Present
Columbia Adult Infusion Center · CUMC
Present
Columbia University
Present

Memorial Sloan-Kettering Cancer Center
New York University Medical Center
Albert Einstein College of Medicine
1997

Research

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2014 · 1,384 citations
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2023 · 435 citations
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
Haematologica · 2018 · 406 citations

Anthony Mato
29 papers
Mazyar Shadman
26 papers
Jennifer Brown
23 papers
Chaitra Ujjani
22 papers
Lindsey Roeker
21 papers · 13 as a fellow
Alan Skarbnik
19 papers
Paul Barr
19 papers
Stephen Schuster
18 papers
CN
Chadi Nabhan
17 papers
Matthew Davids
17 papers
SO
Susan O'Brien
17 papers
Brian Hill
16 papers

Clinical trials

Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Principal investigator · Completed · Phase 2
Nicole Lamanna
2018–2026
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2005–2016
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Study chair · Completed · Phase 3
Memorial Sloan Kettering Cancer Center
1996–2011